Literature DB >> 22010020

Anatomy and biology: two complementary sides of breast cancer prognostication.

Lajos Pusztai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22010020     DOI： 10.1200/JCO.2011.38.2754

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Response.

Authors:  Chiara Cremolini; Fotios Loupakis; Heinz-Josef Lenz
Journal:  J Natl Cancer Inst       Date:  2015-09       Impact factor: 13.506

Review 2.  Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes.

Authors:  Scott D Ramsey; William E Barlow; Ana M Gonzalez-Angulo; Sean Tunis; Laurence Baker; John Crowley; Patricia Deverka; David Veenstra; Gabriel N Hortobagyi
Journal:  Contemp Clin Trials       Date:  2012-09-18       Impact factor: 2.226

3.  ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.

Authors:  Batoul Kaabi; Ghania Belaaloui; Wassila Benbrahim; Kamel Hamizi; Mourad Sadelaoud; Wided Toumi; Hocine Bounecer
Journal:  Pathol Oncol Res       Date:  2015-11-13       Impact factor: 3.201

4.  An unmet need: tailoring extended adjuvant endocrine therapy.

Authors:  G Bianchini; L Gianni
Journal:  Br J Cancer       Date:  2013-11-19       Impact factor: 7.640

5.  Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer.

Authors:  Chang Gong; Weige Tan; Kai Chen; Na You; Shan Zhu; Gehao Liang; Xinhua Xie; Qian Li; Yunjie Zeng; Nengtai Ouyang; Zhihua Li; Musheng Zeng; ShiMei Zhuang; Wan-Yee Lau; Qiang Liu; Dong Yin; Xueqin Wang; Fengxi Su; Erwei Song
Journal:  EBioMedicine       Date:  2016-08-17       Impact factor: 8.143
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.